Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Contemp Clin Trials. 2012 Oct 11;34(1):74–79. doi: 10.1016/j.cct.2012.09.008

Table 3.

Event composition, power, and sample size estimates for the enriched subgroup and its complement

Enriched Subgroup
(n=75)
Complement
(n=350)
Whole Sample
(n=425)
10 year
Cumulative
Incidence
(95% CI)
Sample
size for
80%
power
10 year
Cumulative
Incidence
(95% CI)
Sample
size for
80% power
10 year
Cumulative
Incidence
(95% CI)
Sample size
for
80% power

Metastasis 30%
(15–47%)
231 19%
(13–25%)
378 20%
(15–26%)
349
Competing
Mortality
10%
(3–24%)
- 21%
(16–28%)
- 20%
(15–26 %)
-
Metastasis
or Death
40%
(22–57%)
313 40%
(33–47%)
835 40%
33–47%)
709

CI = confidence interval.